We are live on
!
Find out more
NCM
NEXTBio Capital Management Portfolio holdings
AUM
$215M
This Fund
S&P 500
This Quarter
Est. Return
+20%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$44.9M
(+26%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
10.13%
Top 10 Holdings %
Top 10 Hldgs %
71.05%
Holding
24
New
1
Increased
9
Reduced
7
Closed
–
Top Buys
| 1 |
CMPS
Compass Pathways
CMPS
|
+$8.53M |
| 2 |
Rhythm Pharmaceuticals
RYTM
|
+$5.69M |
| 3 |
Structure Therapeutics
GPCR
|
+$2.66M |
| 4 |
ZBIO
Zenas BioPharma
ZBIO
|
+$2.35M |
| 5 |
TERN
Terns Pharmaceuticals
TERN
|
+$2.19M |
Top Sells
| 1 |
Compass Therapeutics
CMPX
|
+$1.53M |
| 2 |
Oric Pharmaceuticals
ORIC
|
+$1.05M |
| 3 |
EVMN
Evommune Inc
EVMN
|
+$1,000K |
| 4 |
Xenon Pharmaceuticals
XENE
|
+$22.1K |
| 5 |
Vaxcyte
PCVX
|
+$14.2K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TERN
1
DELISTED
Terns Pharmaceuticals
TERN
| $31.9M | 14.8% |
604,534
+53,344
| +10% | +$2.19M |
|
2
Protagonist Therapeutics
PTGX
$8.44B
| $24.2M | 11.24% |
229,619
| – | – |
|
3
Shattuck Labs
STTK
$601M
| $20.3M | 9.4% |
3,149,907
| – | – |
|
4
Vor Biopharma
VOR
$1B
| $17.8M | 8.28% |
999,967
| – | – |
|
|
CMPS
5
Compass Pathways
CMPS
$1.81B
| $11.2M | 5.19% |
2,021,407
+1,268,776
| +169% | +$8.53M |
|
|
6
Rhythm Pharmaceuticals
RYTM
$7.54B
| $11M | 5.09% |
126,078
+58,492
| +87% | +$5.69M |
|
|
7
Xenon Pharmaceuticals
XENE
$6.51B
| $10.7M | 4.95% |
183,225
-479
| -0.3% | -$22.1K |
|
|
PVLA
8
Palvella Therapeutics
PVLA
$2.15B
| $10.3M | 4.79% |
82,686
| – | – |
|
|
ZBIO
9
Zenas BioPharma
ZBIO
$1.82B
| $8.34M | 3.87% |
426,736
+104,753
| +33% | +$2.35M |
|
|
IVA
10
Inventiva
IVA
$1.04B
| $7.4M | 3.44% |
1,333,484
+34,783
| +3% | +$212K |
|
11
Verastem
VSTM
$489M
| $6.93M | 3.22% |
1,306,800
-530
| -0% | -$3.27K |
|
|
CBIO
12
Crescent Biopharma
CBIO
$422M
| $6.85M | 3.18% |
372,856
| – | – |
|
|
13
Oric Pharmaceuticals
ORIC
$1.09B
| $6.63M | 3.08% |
523,619
-92,101
| -15% | -$1.05M |
|
|
14
Structure Therapeutics
GPCR
$3.6B
| $6.42M | 2.98% |
133,239
+38,796
| +41% | +$2.66M |
|
|
15
Vaxcyte
PCVX
$8.12B
| $5.53M | 2.57% |
95,223
-262
| -0.3% | -$14.2K |
|
16
Cogent Biosciences
COGT
$6.58B
| $5.05M | 2.34% |
131,188
+35,369
| +37% | +$1.31M |
|
|
17
Compass Therapeutics
CMPX
$394M
| $4.49M | 2.08% |
848,204
-265,801
| -24% | -$1.53M |
|
|
EVMN
18
Evommune Inc
EVMN
$432M
| $4.23M | 1.96% |
184,063
-44,223
| -19% | -$1,000K |
|
19
Oculis Holding
OCS
$781M
| $3.98M | 1.85% |
149,592
-158
| -0.1% | -$4.18K |
|
20
Zai Lab
ZLAB
$2.18B
| $3.45M | 1.6% |
183,362
+20,000
| +12% | +$371K |
|
21
Disc Medicine
IRON
$2.87B
| $3.37M | 1.56% |
52,655
+9,877
| +23% | +$685K |
|
|
KALV
22
DELISTED
KalVista Pharmaceuticals
KALV
| $2.65M | 1.23% |
131,796
| – | – |
|
23
Summit Therapeutics
SMMT
$12B
| $1.7M | 0.79% |
+89,717
| New | +$1.45M |
|
24
Adicet Bio
ACET
$82.5M
| $1.07M | 0.5% |
157,827
| – | – |
|
Similar funds
OC
EFS
AMIM
VEA
LIWM
1M
CWP
BPW